167 related articles for article (PubMed ID: 30791055)
1. Converting the Distinct Heparins Sourced from Bovine or Porcine Mucosa into a Single Anticoagulant Drug.
Tovar AMF; Vairo BC; Oliveira SMCG; Glauser BF; Santos GRC; Capillé NV; Piquet AA; Santana PS; Micheli KVA; Pereira MS; Vilanova E; Mourão PAS
Thromb Haemost; 2019 Apr; 119(4):618-632. PubMed ID: 30791055
[TBL] [Abstract][Full Text] [Related]
2. Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine.
Glauser BF; Santos GRC; Silva JD; Tovar AMF; Pereira MS; Vilanova E; Mourão PAS
J Thromb Haemost; 2018 Sep; 16(9):1789-1799. PubMed ID: 29968421
[TBL] [Abstract][Full Text] [Related]
3. Heparins Sourced From Bovine and Porcine Mucosa Gain Exclusive Monographs in the Brazilian Pharmacopeia.
Vilanova E; Vairo BC; Oliveira SMCG; Glauser BF; Capillé NV; Santos GRC; Tovar AMF; Pereira MS; Mourão PAS
Front Med (Lausanne); 2019; 6():16. PubMed ID: 30805341
[TBL] [Abstract][Full Text] [Related]
4. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
[TBL] [Abstract][Full Text] [Related]
5. Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?
Aquino RS; Pereira MS; Vairo BC; Cinelli LP; Santos GR; Fonseca RJ; Mourão PA
Thromb Haemost; 2010 May; 103(5):1005-15. PubMed ID: 20216993
[TBL] [Abstract][Full Text] [Related]
6. Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin.
Olson G; Jeske W; Iqbal O; Krupa E; Farooqui A; Siddiqui F; Hoppensteadt D; Kouta A; Fareed J
Clin Appl Thromb Hemost; 2023; 29():10760296231163251. PubMed ID: 36908199
[No Abstract] [Full Text] [Related]
7. Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.
Tovar AM; Santos GR; Capillé NV; Piquet AA; Glauser BF; Pereira MS; Vilanova E; Mourão PA
Sci Rep; 2016 Oct; 6():35619. PubMed ID: 27752111
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin.
Chen J; Yu Y; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Jin C; Jin Y; Yao Y; Xia K; Zhang F; Chen S; Ye X; Linhardt RJ
Clin Appl Thromb Hemost; 2019; 25():1076029619840701. PubMed ID: 30987427
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs.
Santos GRC; Tovar AMF; Capillé NVM; Pereira MS; Pomin VH; Mourão PAS
Drug Discov Today; 2014 Nov; 19(11):1801-1807. PubMed ID: 25019497
[TBL] [Abstract][Full Text] [Related]
10. Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates.
Kouta A; Jeske W; Cera L; Farshid A; Duff R; Hoppensteadt D; Fareed J
Clin Appl Thromb Hemost; 2021; 27():10760296211005544. PubMed ID: 33926250
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic monitoring of unfractionated heparin - trials and tribulations.
Baluwala I; Favaloro EJ; Pasalic L
Expert Rev Hematol; 2017 Jul; 10(7):595-605. PubMed ID: 28632418
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic, Hemostatic, and Anticancer Properties of a Low-Anticoagulant Bovine Heparin.
Santos RP; Tovar AMF; Oliveira MR; Piquet AA; Capillé NV; Oliveira SNMCG; Correia AH; Farias JN; Vilanova E; Mourão PAS
TH Open; 2022 Apr; 6(2):e114-e123. PubMed ID: 35707626
[TBL] [Abstract][Full Text] [Related]
13. M118--a rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes.
Kishimoto TK; Qi YW; Long A; Capila I; Sasisekharan R; Guerrero L; Fier I; Roach J; Venkataraman G
Thromb Haemost; 2009 Nov; 102(5):900-6. PubMed ID: 19888526
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
[TBL] [Abstract][Full Text] [Related]
15. [Reversal for heparins and new anticoagulant treatments].
Kortchinsky T; Vigué B; Samama CM
Ann Fr Anesth Reanim; 2013 Jan; 32(1):37-49. PubMed ID: 23273505
[TBL] [Abstract][Full Text] [Related]
16. [-Anticoagulant drugs-].
Gulba DC
Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
[TBL] [Abstract][Full Text] [Related]
17. Molecular and pharmacologic profile of tinzaparin and a comparable low-molecular-weight bacterial sulfaminoheparosan.
Maddineni J; Ma Q; Hoppensteadt DA; Demir M; Manoni M; Cornelli U; Fareed J
Clin Appl Thromb Hemost; 2004 Jan; 10(1):27-37. PubMed ID: 14979402
[TBL] [Abstract][Full Text] [Related]
18. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
[TBL] [Abstract][Full Text] [Related]
19. Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates.
Kouta A; Hoppensteadt D; Bontekoe E; Jeske W; Duff R; Cera L; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620951851. PubMed ID: 33034200
[TBL] [Abstract][Full Text] [Related]
20. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
Schroeder M; Hogwood J; Gray E; Mulloy B; Hackett AM; Johansen KB
Anal Bioanal Chem; 2011 Jan; 399(2):763-71. PubMed ID: 20922518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
